NEW YORK, September 21, 2016 /PRNewswire/ --
Pre-market, Stock-Callers.com directs its attention to four Healthcare companies, which are: Aetna Inc. (NYSE: AET), Anthem
Inc. (NYSE: ANTM), Humana Inc. (NYSE: HUM), and BioScrip Inc. (NASDAQ: BIOS). According to the MSCI All Country Healthcare index,
the global sector had outperformed the market by over 60% over the past five years, yet had seen a deceleration during the last
12 months. These stocks research reports can be downloaded now by simply registering for free at:
http://stock-callers.com/registration
Aetna
At the close on Tuesday, shares in Hartford, Connecticut-based Aetna Inc. saw a slight
decline of 0.17%, ending the day at $114.63. The stock recorded a trading volume of 959,900 shares.
The Company's shares have advanced 6.75% on an YTD basis. The stock is trading above its 200-day moving average by 2.29%.
Moreover, shares of Aetna, which operates as a health care benefits company in the US, have a Relative Strength Index (RSI) of
39.21.
On September 6th, 2016, Aetna and Piedmont Healthcare announced that the two
organizations have signed a new contract. The agreement will give Aetna members continued in-network access to all Piedmont
facilities and more than 1,400 Piedmont Clinic physicians through February 28th, 2019.
Your complete research report on AET can be retrieved for free at:
http://stock-callers.com/registration/?symbol=AET
Anthem
Shares in Indianapolis, Indiana headquartered Anthem Inc. ended the day 0.44% lower at
$125.76 and with a total trading volume of 1.77 million shares. The stock is trading below its
50-day moving average by 2.38%. Shares of the Company, which through its subsidiaries, operates as a health benefits company in
the US, have an RSI of 43.59.
On September 13th, 2016, research firm Jefferies downgraded the Company's stock
rating from 'Buy' to 'Hold'. The research firm also revised downwards its previous target price from $156
to $138. ANTM free report is just a click away at:
http://stock-callers.com/registration/?symbol=ANTM
Humana
On Tuesday, shares in Louisville, Kentucky headquartered Humana Inc. finished 0.03% lower at
$174.52 with a total trading volume of 394,133 shares. The stock is trading above its 50-day moving
average by 0.64%. Shares of the Company, which together with its subsidiaries, operates as a health and well-being company, have
an RSI of 39.72.
On September 14th, 2016, Oak Street Health and Humana teamed up to add four primary
care practices to Humana's Medicare Advantage Plan networks in Indiana and Michigan. Humana is adding these new primary care practice locations to its network in an effort to improve
access to care and quality of care while increasing patients' ability to manage their own care to improve their health and
well-being. The new practices operated by Oak Street Health accept certain Medicare Advantage plans administered by Humana and do
not accept Medicare Advantage plans administered by other carriers. Sign up for your complimentary research report on HUM at:
http://stock-callers.com/registration/?symbol=HUM
BioScrip
Denver, Colorado-based BioScrip Inc.'s shares recorded a trading volume of 1.24 million
shares at the end of yesterday's session, which was higher than their three months average volume of 785,660 shares. The stock
closed the day at $2.87, dropping 1.71%. The stock has advanced 1.77% in the last one month, 2.87%
in the previous three months, and 64.00% on an YTD basis. The Company's shares are trading above their 50-day and 200-day moving
averages by 7.35% and 24.72%, respectively. Additionally, shares of BioScrip, which provides home infusion services in the US,
have an RSI at 61.26.
On September 9th, 2016, BioScrip announced that it has completed the acquisition of
HS Infusion Holdings, Inc. As a combined company, BioScrip expects to generate over $1 billion in
annual revenue for the fiscal year ending December 31st, 2017. The transaction is
expected to be accretive to BioScrip's financial results and is estimated to generate $14-17
million of synergies in approximately 12-18 months following the closing. The additional financial contribution from Home
Solutions, including anticipated synergies, is anticipated to strengthen BioScrip's balance sheet and leverage profile. Register
for free on Stock-Callers.com and download the latest research report on BIOS at:
http://stock-callers.com/registration/?symbol=BIOS
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed
any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently
reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or
interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a
company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA